Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function
2019 · Proceedings of the National Academy of Sciences · 109 citations
https://doi.org/10.1073/pnas.1908547116
F
Fu Gui
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
1.2K
Citations
18
h-index
23
i10-index
Fu Gui is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: PARP inhibition in cancer therapy & Corneal surgery and disorders & DNA Repair Mechanisms. The author has an h-index of 18, co-authored 47 publications.
ORCID: 0000-0001-8329-7118Papers by this author
worksThe aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK
2022 · Nature Metabolism · 86 citations
https://doi.org/10.1038/s42255-022-00640-7
Trypsin activity governs increased susceptibility to pancreatitis in mice expressing human PRSS1R122H
2019 · Journal of Clinical Investigation · 79 citations
https://doi.org/10.1172/jci130172
Dimeric natural product panepocyclinol A inhibits STAT3 via di-covalent modification
2024 · Acta Pharmaceutica Sinica B · 3 citations
https://doi.org/10.1016/j.apsb.2024.10.001
SPARC: A Multipayload ADC Architecture for Programmable Drug Combinations
2025 · Bioconjugate Chemistry · 1 citations
https://doi.org/10.1021/acs.bioconjchem.5c00239
Deep Learning Models for Predicting Opaque Bubble Layer Morphology of Keratorefractive Lenticule Extraction before Laser Scanning
2026 · Advances in Ophthalmology Practice and Research · 0 citations
https://doi.org/10.1016/j.aopr.2026.02.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat